The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2024

Filed:

Jul. 19, 2022
Applicant:

Baylor College of Medicine, Houston, TX (US);

Inventors:

Vivekkumar B. Patel, Houston, TX (US);

Hongran Wang, Houston, TX (US);

Vivek P. Singh, Houston, TX (US);

Erin Lynn Reineke, Houston, TX (US);

Megumi Mathison, Houston, TX (US);

Austin J. Cooney, Houston, TX (US);

Todd Rosengart, Houston, TX (US);

Assignee:

Baylor College of Medicine, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); A61K 9/00 (2006.01); A61K 31/47 (2006.01); A61K 31/713 (2006.01); A61K 38/17 (2006.01); A61K 48/00 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C12N 5/077 (2010.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/0019 (2013.01); A61K 31/47 (2013.01); A61K 31/713 (2013.01); A61K 38/1709 (2013.01); A61K 48/0058 (2013.01); C07K 14/4702 (2013.01); C07K 14/4746 (2013.01); C07K 14/82 (2013.01); C12N 5/0657 (2013.01); C12N 15/1135 (2013.01); C12N 15/86 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12N 2320/31 (2013.01); C12N 2501/60 (2013.01); C12N 2710/10043 (2013.01); C12N 2740/15043 (2013.01);
Abstract

Embodiments of the disclosure include methods and compositions for in situ cardiac cell regeneration, including transdifferentiation of cardiac cells to cardiomyocytes. In particular embodiments, in situ cardiac cell regeneration encompasses delivery of p63 shRNA and one or both of Hand2 and myocardin, and in specific embodiments further includes one or more of Gata4, Mef2c, and Tbx5. In specific aspects of the disclosure, adult cardiac fibroblasts are reprogrammed into cardiomyocytes using viral vectors that harbor p63 shRNA and one or both of the transcription factors Hand2 and myocardin.


Find Patent Forward Citations

Loading…